Vietnam Health Ministry Says Drug Price Freeze To Continue
This article was originally published in PharmAsia News
Vietnam plans to extend its freeze on pharmaceutical prices beyond the current June 30 expiration date, the Ministry of Health says. In fact, the ministry says any domestic or foreign drug maker who raises prices before June 30 will be fined and closed temporarily. Companies have argued the price of imported materials they use to make their drugs requires them to charge more, sometimes just to break even. The price freeze is in the form of a requirement that local agencies not consider any applications for price increases until June 30, leading many companies to reduce production. (Click here for more
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.